GRI Bio to Present at Alliance Global Partner's 2024 Healthcare Company Showcase

JTC Team, LLC Jenene Thomas (833) 475-8247 GRI@jtcir.com GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio's therapies are designed to target the activity of NKT cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis. NKT cells are innate-like T cells that share properties of both NK and T cells and are a ...